Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1876 entries
Sorted by: Best Match Show Resources per page
Prostate cancer: Potential of PARP inhibition plus ADT in prostate cancer.

Nature reviews. Urology

Kelsey R.
PMID: 28926548
Nat Rev Urol. 2017 Nov;14(11):640. doi: 10.1038/nrurol.2017.156. Epub 2017 Sep 19.

No abstract available.

Cite
Kelsey R. Prostate cancer: Potential of PARP inhibition plus ADT in prostate cancer. Nat Rev Urol. 2017;14(11):640doi: 10.1038/nrurol.2017.156.
Kelsey, R. (2017). Prostate cancer: Potential of PARP inhibition plus ADT in prostate cancer. Nature reviews. Urology, 14(11), 640. https://doi.org/10.1038/nrurol.2017.156
Kelsey, Rebecca. "Prostate cancer: Potential of PARP inhibition plus ADT in prostate cancer." Nature reviews. Urology vol. 14,11 (2017): 640. doi: https://doi.org/10.1038/nrurol.2017.156
Kelsey R. Prostate cancer: Potential of PARP inhibition plus ADT in prostate cancer. Nat Rev Urol. 2017 Nov;14(11):640. doi: 10.1038/nrurol.2017.156. Epub 2017 Sep 19. PMID: 28926548.
Copy Download .nbib Format: NLM
Prostate cancer: Resveratrol inhibits the AR.

Nature reviews. Urology

Fenner A.
PMID: 28976500
Nat Rev Urol. 2017 Nov;14(11):642. doi: 10.1038/nrurol.2017.159. Epub 2017 Oct 04.

No abstract available.

Cite
Fenner A. Prostate cancer: Resveratrol inhibits the AR. Nat Rev Urol. 2017;14(11):642doi: 10.1038/nrurol.2017.159.
Fenner, A. (2017). Prostate cancer: Resveratrol inhibits the AR. Nature reviews. Urology, 14(11), 642. https://doi.org/10.1038/nrurol.2017.159
Fenner, Annette. "Prostate cancer: Resveratrol inhibits the AR." Nature reviews. Urology vol. 14,11 (2017): 642. doi: https://doi.org/10.1038/nrurol.2017.159
Fenner A. Prostate cancer: Resveratrol inhibits the AR. Nat Rev Urol. 2017 Nov;14(11):642. doi: 10.1038/nrurol.2017.159. Epub 2017 Oct 04. PMID: 28976500.
Copy Download .nbib Format: NLM
Sexual dysfunction: Shockwaves for erectile dysfunction.

Nature reviews. Urology

Kelsey R.
PMID: 26718457
Nat Rev Urol. 2016 Feb;13(2):63. doi: 10.1038/nrurol.2015.310. Epub 2015 Dec 31.

No abstract available.

Cite
Kelsey R. Sexual dysfunction: Shockwaves for erectile dysfunction. Nat Rev Urol. 2015;13(2):63doi: 10.1038/nrurol.2015.310.
Kelsey, R. (2016). Sexual dysfunction: Shockwaves for erectile dysfunction. Nature reviews. Urology, 13(2), 63. https://doi.org/10.1038/nrurol.2015.310
Kelsey, Rebecca. "Sexual dysfunction: Shockwaves for erectile dysfunction." Nature reviews. Urology vol. 13,2 (2016): 63. doi: https://doi.org/10.1038/nrurol.2015.310
Kelsey R. Sexual dysfunction: Shockwaves for erectile dysfunction. Nat Rev Urol. 2016 Feb;13(2):63. doi: 10.1038/nrurol.2015.310. Epub 2015 Dec 31. PMID: 26718457.
Copy Download .nbib Format: NLM
Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts.

Reviews in urology

Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA.
PMID: 25009446
Rev Urol. 2014;16(2):67-75.

Proton beam therapy for prostate cancer has become a source of controversy in the urologic community, and the rapid dissemination and marketing of this technology has led to many patients inquiring about this therapy. Yet the complexity of the...

Cite
Wisenbaugh ES, Andrews PE, Ferrigni RG, et al. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014;16(2):67-75
Wisenbaugh, E. S., Andrews, P. E., Ferrigni, R. G., Schild, S. E., Keole, S. R., Wong, W. W., & Vora, S. A. (2014). Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Reviews in urology, 16(2), 67-75.
Wisenbaugh, Eric S, et al. "Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts." Reviews in urology vol. 16,2 (2014): 67-75.
Wisenbaugh ES, Andrews PE, Ferrigni RG, Schild SE, Keole SR, Wong WW, Vora SA. Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts. Rev Urol. 2014;16(2):67-75. PMID: 25009446; PMCID: PMC4080851.
Copy Download .nbib Format: NLM
Kidney cancer: Quality-of-life outcomes in patients with small renal masses.

Nature reviews. Urology

Matin SF.
PMID: 27400666
Nat Rev Urol. 2016 Aug;13(8):443-4. doi: 10.1038/nrurol.2016.124. Epub 2016 Jul 12.

No abstract available.

Cite
Matin SF. Kidney cancer: Quality-of-life outcomes in patients with small renal masses. Nat Rev Urol. 2016;13(8):443-4doi: 10.1038/nrurol.2016.124.
Matin, S. F. (2016). Kidney cancer: Quality-of-life outcomes in patients with small renal masses. Nature reviews. Urology, 13(8), 443-4. https://doi.org/10.1038/nrurol.2016.124
Matin, Surena F. "Kidney cancer: Quality-of-life outcomes in patients with small renal masses." Nature reviews. Urology vol. 13,8 (2016): 443-4. doi: https://doi.org/10.1038/nrurol.2016.124
Matin SF. Kidney cancer: Quality-of-life outcomes in patients with small renal masses. Nat Rev Urol. 2016 Aug;13(8):443-4. doi: 10.1038/nrurol.2016.124. Epub 2016 Jul 12. PMID: 27400666.
Copy Download .nbib Format: NLM
Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice.

Reviews in urology

McMahon GC, Brown GA.
PMID: 29472828
Rev Urol. 2017;19(4):248-251. doi: 10.3909/riu0782.

No abstract available.

Cite
McMahon GC, Brown GA. Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice. Rev Urol. 2017;19(4):248-251doi: 10.3909/riu0782.
McMahon, G. C., & Brown, G. A. (2017). Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice. Reviews in urology, 19(4), 248-251. https://doi.org/10.3909/riu0782
McMahon, Gregory C, and Brown, Gordon A. "Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice." Reviews in urology vol. 19,4 (2017): 248-251. doi: https://doi.org/10.3909/riu0782
McMahon GC, Brown GA. Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice. Rev Urol. 2017;19(4):248-251. doi: 10.3909/riu0782. PMID: 29472828; PMCID: PMC5811882.
Copy Download .nbib Format: NLM
Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.

Reviews in urology

Murray KS, Akin O, Coleman JA.
PMID: 29472832
Rev Urol. 2017;19(4):268-272. doi: 10.3909/riu0755.

Salvage treatment options after localized primary treatment failure of prostate cancer are limited and associated with risk for serious complications. We report on the management details of a 57-year-old African American man treated with partial-gland ablation using irreversible electroporation...

Cite
Murray KS, Akin O, Coleman JA. Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy. Rev Urol. 2017;19(4):268-272doi: 10.3909/riu0755.
Murray, K. S., Akin, O., & Coleman, J. A. (2017). Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy. Reviews in urology, 19(4), 268-272. https://doi.org/10.3909/riu0755
Murray, Katie S, et al. "Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy." Reviews in urology vol. 19,4 (2017): 268-272. doi: https://doi.org/10.3909/riu0755
Murray KS, Akin O, Coleman JA. Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy. Rev Urol. 2017;19(4):268-272. doi: 10.3909/riu0755. PMID: 29472832; PMCID: PMC5811886.
Copy Download .nbib Format: NLM
The Role of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy.

Reviews in urology

Lai WS, Assimos D.
PMID: 27162507
Rev Urol. 2016;18(1):10-4.

Postoperative sepsis is the most common cause of mortality after percutaneous nephrolithotomy (PCNL) procedures. Studies investigating the use of antibiotics in PCNL patients have shown that prophylactic antibiotic regimens can reduce the rate of postoperative infectious complications. In addition,...

Cite
Lai WS, Assimos D. The Role of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy. Rev Urol. 2016;18(1):10-4
Lai, W. S., & Assimos, D. (2016). The Role of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy. Reviews in urology, 18(1), 10-4.
Lai, Win Shun, and Assimos, Dean. "The Role of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy." Reviews in urology vol. 18,1 (2016): 10-4.
Lai WS, Assimos D. The Role of Antibiotic Prophylaxis in Percutaneous Nephrolithotomy. Rev Urol. 2016;18(1):10-4. PMID: 27162507; PMCID: PMC4859923.
Copy Download .nbib Format: NLM
Prostate cancer: The importance of the mitochondrial genome.

Nature reviews. Urology

Thoma C.
PMID: 29039419
Nat Rev Urol. 2017 Dec;14(12):701. doi: 10.1038/nrurol.2017.174. Epub 2017 Oct 17.

No abstract available.

Cite
Thoma C. Prostate cancer: The importance of the mitochondrial genome. Nat Rev Urol. 2017;14(12):701doi: 10.1038/nrurol.2017.174.
Thoma, C. (2017). Prostate cancer: The importance of the mitochondrial genome. Nature reviews. Urology, 14(12), 701. https://doi.org/10.1038/nrurol.2017.174
Thoma, Clemens. "Prostate cancer: The importance of the mitochondrial genome." Nature reviews. Urology vol. 14,12 (2017): 701. doi: https://doi.org/10.1038/nrurol.2017.174
Thoma C. Prostate cancer: The importance of the mitochondrial genome. Nat Rev Urol. 2017 Dec;14(12):701. doi: 10.1038/nrurol.2017.174. Epub 2017 Oct 17. PMID: 29039419.
Copy Download .nbib Format: NLM
Adenomatoid Tumor of the Testis Arising From the Tunica Albuginea.

Reviews in urology

Sun AY, Polackwich AS, Sabanegh ES.
PMID: 27162515
Rev Urol. 2016;18(1):51-3.

Adenomatoid tumors are the most common paratesticular tumor. Although they primarily arise from the epididymis, they can rarely occur as an isolated intratesticular mass. These tumors are benign and surgical excision is curative. We present a case of a...

Cite
Sun AY, Polackwich AS, Sabanegh ES. Adenomatoid Tumor of the Testis Arising From the Tunica Albuginea. Rev Urol. 2016;18(1):51-3
Sun, A. Y., Polackwich, A. S., & Sabanegh, E. S. (2016). Adenomatoid Tumor of the Testis Arising From the Tunica Albuginea. Reviews in urology, 18(1), 51-3.
Sun, Andrew Y, et al. "Adenomatoid Tumor of the Testis Arising From the Tunica Albuginea." Reviews in urology vol. 18,1 (2016): 51-3.
Sun AY, Polackwich AS, Sabanegh ES. Adenomatoid Tumor of the Testis Arising From the Tunica Albuginea. Rev Urol. 2016;18(1):51-3. PMID: 27162515; PMCID: PMC4859931.
Copy Download .nbib Format: NLM
From the President's Desk: Looking Ahead at 2015.

Reviews in urology

Kirsh GM.
PMID: 25548546
Rev Urol. 2014;16(4):189-90.

No abstract available.

Cite
Kirsh GM. From the President's Desk: Looking Ahead at 2015. Rev Urol. 2014;16(4):189-90
Kirsh, G. M. (2014). From the President's Desk: Looking Ahead at 2015. Reviews in urology, 16(4), 189-90.
Kirsh, Gary M. "From the President's Desk: Looking Ahead at 2015." Reviews in urology vol. 16,4 (2014): 189-90.
Kirsh GM. From the President's Desk: Looking Ahead at 2015. Rev Urol. 2014;16(4):189-90. PMID: 25548546; PMCID: PMC4274176.
Copy Download .nbib Format: NLM
Testicular sclerosing sertoli cell tumor: a case report and review of the literature.

Reviews in urology

Coleman S, Barazani Y, Roma AA, Sabanegh E.
PMID: 25548547
Rev Urol. 2014;16(4):191-3.

Sertoli cell tumors are very rare testicular tumors, representing 0.4% to 1.5% of all testicular malignancies. They are subclassified as classic, large-cell calcifying, and sclerosing Sertoli cell tumors (SSCT) based on distinct clinical features. Only 42 cases of SSCTs...

Cite
Coleman S, Barazani Y, Roma AA, et al. Testicular sclerosing sertoli cell tumor: a case report and review of the literature. Rev Urol. 2014;16(4):191-3
Coleman, S., Barazani, Y., Roma, A. A., & Sabanegh, E. (2014). Testicular sclerosing sertoli cell tumor: a case report and review of the literature. Reviews in urology, 16(4), 191-3.
Coleman, Sarah, et al. "Testicular sclerosing sertoli cell tumor: a case report and review of the literature." Reviews in urology vol. 16,4 (2014): 191-3.
Coleman S, Barazani Y, Roma AA, Sabanegh E. Testicular sclerosing sertoli cell tumor: a case report and review of the literature. Rev Urol. 2014;16(4):191-3. PMID: 25548547; PMCID: PMC4274177.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1876 entries